KZA
Click for more information
0.00% 8.0¢ kazia therapeutics limited

Ann: Kazia releases final data from P2 paxalisib trial, page-19

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. onesurfed
    2,073 Posts.
    lightbulb Created with Sketch. 443
    clock Created with Sketch.
    03/12/21
    11:03
    Post #: 58047234
    The study was in the category of the 2/3 of patients Temo does not work on, unmethylated MGMT promoter status patients.
    Last edited by onesurfed: 03/12/21
    KZA Price at posting: $1.45 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Form 20-F filed to explore U.S. market opportunities through proposed Nasdaq ADS listing, aligning with strategic global growth goals
right-arrow Created with Sketch.
NEWS Trending Thread: $13.0 million Institutional Placement
right-arrow Created with Sketch.
NEWS Canyon-1H well drilling advancing as planned, with promising results observed and key milestones on track for completion by late October
right-arrow Created with Sketch.
NEWS What's causing the cost-of-living crisis, and how to navigate it
right-arrow Created with Sketch.
NVU Nanoveu commences crucial benchmark testing for System-on-aChip (SoC) Semiconductor technology
right-arrow Created with Sketch.
NVU Nanoveu To Acquire Leading SoC Semiconductor Company
right-arrow Created with Sketch.
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.